Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome

Abstract

Objectives Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular morbidity and mortality. The aim of this study was to assess whether the 10-year risk for cardiovascular disease in newly diagnosed patients with OSAS is increased. Materials and Methods Recently diagnosed, with polysomnography, consecutive OSAS patients were included. The Systematic Coronary Risk Evaluation (SCORE) and the Framingham Risk Score (FRS) were used to estimate the 10-year risk for cardiovascular disease. Results Totally, 393 individuals (73.3% males), scheduled to undergo a polysomnographic study with symptoms indicative of OSAS, were enrolled. According to apnea-hypopnea index (AHI), subjects were divided in four groups: mild OSAS (AHI 5–14.9/h) was diagnosed in 91 patients (23.2%), moderate OSAS (AHI 15–29.9/h) in 58 patients (14.8%), severe OSAS (AHI > 30/h) in 167 patients (42.5%), while 77 individuals (19.6%) had an AHI < 5/h and served as controls. Increased severity of OSAS was associated with increased SCORE (p < 0.001) and FRS values (p < 0.001). More specifically, a significant correlation was observed both between AHI and SCORE (r=0.251, p < 0.001) and AHI and FRS values (r=0.291, p < 0.001). Furthermore, a negative correlation was observed between FRS values and sleep efficiency (r=−0.224, p=0.006). Conclusions The 10-year risk for cardiovascular morbidity and mortality seems to increase with severity of OSAS. Physicians should bear this finding in mind, in order to seek for and consecutively eliminate risk factors for cardiovascular disease and to prevent future cardiovascular events in OSAS patients.

Cardiovascular disease and obstructive sleep apnea: an underappreciated role for increased platelet activity?

“…An issue which often arises after initiation of CPAP, apart from adherence, is disease monitoring in relation to effectively reducing and/or preventing concomitant CVD. Accumulating data point to an increasing number of biomarkers [4] or well established scores [5], to enable diagnosis of OSAS-related CVD events.…”

Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome‐chronic obstructive pulmonary disease (overlap syndrome)

“…Recent studies have shown that OSAS patients may carry an increased risk of CVD, as assessed by the two validated risk scores, the systematic coronary risk evaluation (SCORE) and the Framingham risk score (FRS) . FRS assesses the 10‐year risk for cardiovascular (CV) morbidity and mortality in patients without known CVD, whereas SCORE evaluates the 10‐year risk of death from CVD .…”

Adiponectin Relieves Human Adult Cardiac Myocytes Injury Induced by Intermittent Hypoxia

“…Intermittent hypoxia (IH) is one of the most important pathological hallmark of OSAS. Previous reports showed that IH was associated with cardiovascular disease [2,3]. IH has also been shown to induce left ventricular remodeling [4].…”